Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from 4DMedical Ltd ( (AU:4DX) ).
4DMedical Ltd has announced a target market determination related to the issuance of new quoted options and piggyback options, which are tied to the company’s shares. These options are part of a prospectus set to be lodged in March 2025, aimed at institutional and sophisticated investors, eligible shareholders, and sub-underwriters. The options are designed to facilitate the trade of shares upon exercise, with the issuance subject to shareholder approval and ASX quotation requirements. This move is expected to enhance the company’s market positioning by potentially increasing share liquidity and attracting more investors.
More about 4DMedical Ltd
4DMedical Ltd is a company operating in the medical technology industry, focusing on developing advanced imaging solutions. Its primary product is the CT:VQ™ ventilation and perfusion technology, which is aimed at improving respiratory diagnostics.
YTD Price Performance: -25.00%
Average Trading Volume: 927,646
Technical Sentiment Signal: Buy
Current Market Cap: A$153.7M
See more data about 4DX stock on TipRanks’ Stock Analysis page.